$5.41
0.193.64%
Pre-Market: 8:10 AM EDT
Comments
Loading...
Annovis Bio (ANVS) Forecast
NewsEarningsAnnovis Bio (ANVS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAnnovis Bio (NYSE:ANVS) Stock Quotes, Forecast and News Summary
Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Annovis Bio (ANVS) stock?
You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.
Who are Annovis Bio (ANVS) competitors?
Other companies in Annovis Bio’s space includes: Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), PepGen (NASDAQ:PEPG) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for Annovis Bio (ANVS) stock?
Annovis Bio has a consensus price target of $33.67.
What is the current price for Annovis Bio (ANVS)?
The stock price for Annovis Bio (NYSE: ANVS) is $5.41 last updated January 22, 2025 at 8:10 AM EST.
Does Annovis Bio (ANVS) pay a dividend?
There are no upcoming dividends for Annovis Bio.
When is Annovis Bio (NYSE:ANVS) reporting earnings?
Annovis Bio’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Annovis Bio (ANVS) going to split?
There is no upcoming split for Annovis Bio.
What sector and industry does Annovis Bio (ANVS) operate in?
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.